Home  /  Resource Library  /  Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

Key points – Circulating tumor DNA is as an easily accessible source of tumor DNA for cHL genotyping and is a radiation-free tool to track residual disease in Hodgkin lymphoma. Abstract only.